Related references
Note: Only part of the references are listed.18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial
Miguel Quintela-Fandino et al.
CLINICAL CANCER RESEARCH (2017)
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Ramon Colomer et al.
CURRENT DRUG TARGETS (2017)
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
A. Strickaert et al.
ONCOGENE (2017)
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives
Xilan Yu et al.
ONCOTARGET (2017)
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
J. A. Menendez et al.
ONCOGENESIS (2017)
Crystal Structure and Substrate Specificity of Human Thioesterase 2: INSIGHTS INTO THE MOLECULAR BASIS FOR THE MODULATION OF FATTY ACID SYNTHASE
Melissa K. Ritchie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
Ramasamy Paulmurugan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET
Elena Hernandez-Agudo et al.
MOLECULAR ONCOLOGY (2016)
Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism
Yanyan Cai et al.
CANCER CELL (2016)
Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis
Camille Lehuede et al.
CANCER RESEARCH (2016)
Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?
Katherine Eason et al.
CANCER RESEARCH (2016)
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
Ariadna Giro-Perafita et al.
CLINICAL CANCER RESEARCH (2016)
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Simon Lord et al.
CURRENT DRUG TARGETS (2016)
Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors
Maria Jose Bueno et al.
CURRENT DRUG TARGETS (2016)
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
Alexander M. Scherbakov et al.
IUBMB LIFE (2016)
Acetate as a Metabolic and Epigenetic Modifier of Cancer Therapy
Diane M. Jaworski et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes
Jean-Pierre Etchegaray et al.
MOLECULAR CELL (2016)
Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines
Tanner K. Hill et al.
MOLECULAR PHARMACEUTICS (2016)
Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy
Aarohi Bhargava-Shah et al.
NANOMEDICINE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Metformin and cancer: Quo vadis et cui bono?
Javier A. Menendez et al.
ONCOTARGET (2016)
Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: Evidence for metformin-based starvation strategies in BRCA1 carriers
Elisabet Cuyas et al.
ONCOTARGET (2016)
Repurposing metformin for cancer treatment: current clinical studies
Young Kwang Chae et al.
ONCOTARGET (2016)
Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
Gabriela Jimenez-Valerio et al.
CELL REPORTS (2016)
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
Elizabeth Allen et al.
CELL REPORTS (2016)
Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation
Eoin McDonnell et al.
CELL REPORTS (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
Metabolic control of epigenetics in cancer
Adam Kinnaird et al.
NATURE REVIEWS CANCER (2016)
Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2+ Breast Cancer
Yazan Alwarawrah et al.
CELL CHEMICAL BIOLOGY (2016)
Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
Zachary T. Schug et al.
CANCER CELL (2015)
Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: Overview and application
Yukie Yoshii et al.
CANCER LETTERS (2015)
Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
M. Robertson-Tessi et al.
CANCER RESEARCH (2015)
Metabolic control of cancer cell stemness: Lessons from iPS cells
Javier A. Menendez
CELL CYCLE (2015)
Molecular Pathways: Fatty Acid Synthase
Suzanne F. Jones et al.
CLINICAL CANCER RESEARCH (2015)
Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance
Ming Luo et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs
Javier A. Menendez
CURRENT PHARMACEUTICAL DESIGN (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
Shany Koren et al.
MOLECULAR CELL (2015)
Toward understanding and exploiting tumor heterogeneity
Ash A. Alizadeh et al.
NATURE MEDICINE (2015)
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
Adriana Blancafort et al.
PLOS ONE (2015)
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
Camille Loubiere et al.
ONCOTARGET (2015)
MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
Richa Singh et al.
SCIENTIFIC REPORTS (2015)
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
Takla Griss et al.
PLOS BIOLOGY (2015)
A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms
Maria J. Bueno et al.
EBIOMEDICINE (2015)
Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
Richard Ventura et al.
EBIOMEDICINE (2015)
Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
L. Jiang et al.
ONCOGENE (2015)
Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes
Sewha Kim et al.
PLOS ONE (2015)
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer
Yoon Yang Jung et al.
PLOS ONE (2015)
Tumorigenesis: it takes a village
Doris P. Tabassum et al.
NATURE REVIEWS CANCER (2015)
Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2014)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
Junqin Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET
David Y. Lewis et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site
Mary Ann Hardwicke et al.
NATURE CHEMICAL BIOLOGY (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
Mary Jo Cantoria et al.
METABOLOMICS (2014)
Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment
Javier A. Menendez et al.
ONCOTARGET (2014)
Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
Reema S. Wahdan-Alaswad et al.
HORMONES & CANCER (2014)
Metabostemness: a new cancer hallmark
Javier A. Menendez et al.
FRONTIERS IN ONCOLOGY (2014)
Metformin directly acts on mitochondria to alter cellular bioenergetics
Sylvia Andrzejewski et al.
CANCER & METABOLISM (2014)
Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor
David A. Carlson et al.
ACS CHEMICAL BIOLOGY (2013)
The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
Javier A. Menendez et al.
CELL CYCLE (2013)
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
Bruna Corominas-Faja et al.
CELL CYCLE (2013)
The mitochondrial H+-ATP synthase and the lipogenic switch New core components of metabolic reprogramming in induced pluripotent stem (iPS) cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2013)
Differential Pharmacologic Properties of the Two C75 Enantiomers: (+)-C75 Is a Strong Anorectic Drug; (-)-C75 Has Antitumor Activity
Kamil Makowski et al.
CHIRALITY (2013)
The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
Laura M. DeFord-Watts et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2013)
Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade
Bang-Bao Tao et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
Madhuri Sankaranarayanapillai et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer
P. R. Pandey et al.
ONCOGENE (2013)
Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation
Johan D. Oslob et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
F. Seguin et al.
BRITISH JOURNAL OF CANCER (2012)
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Kavita Bhalla et al.
CANCER PREVENTION RESEARCH (2012)
Finding a Panacea among Combination Cancer Therapies
Ryuji Yamaguchi et al.
CANCER RESEARCH (2012)
Challenges in targeting cancer metabolism for cancer therapy
Ryuji Yamaguchi et al.
EMBO REPORTS (2012)
New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
Carlos Turrado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Puspa R. Pandey et al.
Recent Patents on Anti-Cancer Drug Discovery (2012)
Cancer Cell Metabolism: One Hallmark, Many Faces
Jason R. Cantor et al.
CANCER DISCOVERY (2012)
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
Puspa R. Pandey et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Nuclear Factor-κB (NF-κB) Mediates a Protective Response in Cancer Cells Treated with Inhibitors of Fatty Acid Synthase
Colleen R. M. Lemmon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Serum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosis
Jorge Joven et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Metabolic alterations and targeted therapies in prostate cancer
Richard Flavin et al.
JOURNAL OF PATHOLOGY (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
A novel inhibitor of fatty acid synthase shows activity against HER2+breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Teresa Puig et al.
BREAST CANCER RESEARCH (2011)
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2(+) breast cancer
G. Oliveras et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives
Javier A. Menendez
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Tumor heterogeneity: Causes and consequences
Andriy Marusyk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection
Gerard Aragones et al.
BMC GASTROENTEROLOGY (2010)
De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
Evelien Rysman et al.
CANCER RESEARCH (2010)
Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
A. Vazquez-Martin et al.
CURRENT MOLECULAR MEDICINE (2010)
Extracellular Fatty Acid Synthase: A Possible Surrogate Biomarker of Insulin Resistance
Jose Manuel Fernandez-Real et al.
DIABETES (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
Fatty acid synthase as a potential therapeutic target in cancer
Richard Flavin et al.
FUTURE ONCOLOGY (2010)
Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
Stefanie M. Ueda et al.
JOURNAL OF ONCOLOGY (2010)
AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid Synthase
Cristina Oliveras-Ferraros et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
Teresa Puig et al.
CLINICAL CANCER RESEARCH (2009)
Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer
Javier A. Menendez et al.
CLINICAL CHEMISTRY (2009)
Serum concentrations of extracellular fatty acid synthase in patients with steatohepatitis
Judit Marsillach et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Tumor suppressors and cell metabolism: a recipe for cancer growth
Russell G. Jones et al.
GENES & DEVELOPMENT (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Gene expression in the human mammary epithelium during lactation: the milk fat globule transcriptome
Patricia D. Maningat et al.
PHYSIOLOGICAL GENOMICS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
β-lactam congeners of orlistat as inhibitors of fatty acid synthase
Wei Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1
Eiji Furuta et al.
CANCER RESEARCH (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A. Vazquez-Martin et al.
CELL PROLIFERATION (2008)
Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors
Hajime Orita et al.
CLINICAL CANCER RESEARCH (2008)
Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-ketoacyl reductase reaction
Maria Jesus Vazquez et al.
FEBS JOURNAL (2008)
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
Marco A. Carvalho et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Synthesis of novel β-lactone inhibitors of fatty acid synthase
Robyn D. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
Hailan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
BRCA1 and acetyl-CoA carboxylase:: The metabolic syndrome of breast cancer
Joan Brunet et al.
MOLECULAR CARCINOGENESIS (2008)
The crystal structure of a mammalian fatty acid synthase
Timm Maier et al.
SCIENCE (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
Charles W. Pemble et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells
Weibo Zhou et al.
CANCER RESEARCH (2007)
Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis
Majida Esslimani-Sahla et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Mediterranean dietary traditions for the molecular treatment of human cancer:: Anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9)
Javier A. Menendez et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?
Ruth Lupu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase
Gil Ma et al.
ORGANIC LETTERS (2006)
3-aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors
Alexey Rivkin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells
Javier A. Menendez et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
Practical, catalytic, asymmetric synthesis of β-lactones via a sequential ketene dimerization/hydrogenation process:: Inhibitors of the thioesterase domain of fatty acid synthase
Vikram C. Purohit et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells
S Bandyopadhyay et al.
CANCER RESEARCH (2006)
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
J Wang et al.
NATURE (2006)
Architecture of mammalian fatty acid synthase at 4.5 Å resolution
T Maier et al.
SCIENCE (2006)
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis
XS Liu et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Minireview: Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
Ruth Lupu et al.
ENDOCRINOLOGY (2006)
Inhibition of fatty acid synthase by polyphenols
WX Tian
CURRENT MEDICINAL CHEMISTRY (2006)
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells:: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
JA Menendez et al.
ANNALS OF ONCOLOGY (2005)
Targeting fatty acid synthase:: Potential for therapeutic intervention in Her-2/neu-: Overexpressing breast cancer
JA Menendez et al.
DRUG NEWS & PERSPECTIVES (2005)
Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates
AR Rendina et al.
BIOCHEMICAL JOURNAL (2005)
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (Paclitaxel)-induced cytotoxicity
JA Menendez et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
New hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis
MV Chakravarthy et al.
CELL METABOLISM (2005)
Structure and molecular organization of mammalian fatty acid synthase
FJ Asturias et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase
JM McFadden et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity
K Brusselmans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice
PM Alli et al.
ONCOGENE (2005)
Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells
JA Menendez et al.
MEDICAL HYPOTHESES (2005)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
SJ Kridel et al.
CANCER RESEARCH (2004)
Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER-2/neu-overexpressing human breast cancer cells to docetaxel (taxotere)
JA Menendez et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibitory effects of flavonoids on animal fatty acid synthase
BH Li et al.
JOURNAL OF BIOCHEMISTRY (2004)
Fatty acid synthase: A metabolic oncogene in prostate cancer?
A Baron et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma
V Sebastiani et al.
GYNECOLOGIC ONCOLOGY (2004)
Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells
JA Menendez et al.
ONCOGENE (2004)
Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation
JA Menendez et al.
MOLECULAR CARCINOGENESIS (2004)
Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells
K Brusselmans et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A flexible route to (5R)-thiolactomycin, a naturally occurring inhibitor of fatty acid synthesis
JM McFadden et al.
ORGANIC LETTERS (2002)
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity
JN Thupari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides
T Shimokawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach
T Kusakabe et al.
HISTOPATHOLOGY (2002)
Green tea epigallocatechin gallate: A natural inhibitor of fatty-acid synthase
X Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity
JN Thupari et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients
Y Wang et al.
CANCER LETTERS (2001)
Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma
T Nemoto et al.
PATHOBIOLOGY (2001)
Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissues
RE Wilentz et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2000)
Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors
TM Loftus et al.
SCIENCE (2000)
Share Paper
